Canbreal Therodiagnostics International Inc.
This article was originally published in Start Up
Canbreal Therodiagnostics is developing diagnostic kits that may help women gauge their risk of developing breast cancer. Analysis of two estrogen dependent cellular markers associated with increased cell division and a cancer's ability to metastasize may provide some quantitative measure of breast cancer risk
You may also be interested in...
As an industry, women's health is in its infancy. It has yet to develop beyond a collection of niche specialties in reproductive medicine and breast cancer.
Keeping Track: Submissions Galore Start The New Year; US FDA Clears New Indications For Enhertu, Xalkori
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker
Vacci Prep is first “supplement to establish a standard of care for consumers when preparing their immune system for vaccinations,” Dentovations says.